ATE441430T1 - Faktor viia oder faktor viia äquivaltenen zur prävention oder abschwächung des wachstums von hämorrhagien und/oder der ídemerzeugung nach intrazerebraler hämorrhagie (ich) - Google Patents
Faktor viia oder faktor viia äquivaltenen zur prävention oder abschwächung des wachstums von hämorrhagien und/oder der ídemerzeugung nach intrazerebraler hämorrhagie (ich)Info
- Publication number
- ATE441430T1 ATE441430T1 AT05756838T AT05756838T ATE441430T1 AT E441430 T1 ATE441430 T1 AT E441430T1 AT 05756838 T AT05756838 T AT 05756838T AT 05756838 T AT05756838 T AT 05756838T AT E441430 T1 ATE441430 T1 AT E441430T1
- Authority
- AT
- Austria
- Prior art keywords
- hemorrhagia
- factor viia
- preventing
- intracerebral
- attenuation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400972 | 2004-06-21 | ||
DKPA200400981 | 2004-06-23 | ||
PCT/EP2005/052890 WO2005123118A1 (en) | 2004-06-21 | 2005-06-21 | Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE441430T1 true ATE441430T1 (de) | 2009-09-15 |
Family
ID=35058275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05756838T ATE441430T1 (de) | 2004-06-21 | 2005-06-21 | Faktor viia oder faktor viia äquivaltenen zur prävention oder abschwächung des wachstums von hämorrhagien und/oder der ídemerzeugung nach intrazerebraler hämorrhagie (ich) |
Country Status (13)
Country | Link |
---|---|
US (2) | US20060019894A1 (de) |
EP (1) | EP1761274B1 (de) |
JP (2) | JP5523671B2 (de) |
KR (1) | KR20070027709A (de) |
AT (1) | ATE441430T1 (de) |
AU (1) | AU2005253749A1 (de) |
BR (1) | BRPI0512316A (de) |
CA (1) | CA2570330A1 (de) |
DE (1) | DE602005016406D1 (de) |
ES (1) | ES2331653T3 (de) |
MX (1) | MXPA06015045A (de) |
RU (1) | RU2006144397A (de) |
WO (1) | WO2005123118A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1906993A2 (de) * | 2005-07-15 | 2008-04-09 | Novo Nordisk Health Care AG | Verwendung von faktor viia oder faktor viia-äquivalenten zur prävention oder abschwächung von hämorrhagiewachstum und/oder ödembildung nach interzerebraler blutung (ich) bei patienten unter einer anti-thrombozyten-therapie |
JP2011509978A (ja) * | 2008-01-18 | 2011-03-31 | ノボ ノルディスク ヘルス ケア アーゲー | 選択されたICH患者亜集団における脳内出血(ICH)後の出血拡大、及び/又は浮腫生成の予防又は減弱のための、第VIIa因子又は第VIIa因子等価物の使用 |
TWI538916B (zh) | 2008-04-11 | 2016-06-21 | 介控生化科技公司 | 經修飾的因子vii多肽和其用途 |
JP5911435B2 (ja) * | 2010-02-22 | 2016-04-27 | エッジ セラピューティクス インコーポレイテッド | 脳の出血状態を治療するための方法及び組成物 |
KR20160093731A (ko) * | 2014-01-24 | 2016-08-08 | 화이자 인코포레이티드 | 뇌내 출혈을 치료하기 위한 조성물 및 방법 |
EP3833381B1 (de) | 2019-08-15 | 2022-08-03 | Catalyst Biosciences, Inc. | Modifizierte faktor-vii-polypeptide zur subkutanen verabreichung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058661A1 (en) * | 1997-06-23 | 1998-12-30 | Novo Nordisk A/S | Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
US7015194B2 (en) * | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
EP1216709A1 (de) * | 2000-12-21 | 2002-06-26 | Boehringer Ingelheim Pharma KG | Verwendung von aktiviertem Gerinnungsfaktor VII zur Behandlung von durch thrombolytische Therapie-induzierten wichtigen Blutungen |
ATE386538T1 (de) * | 2001-02-05 | 2008-03-15 | Novo Nordisk Healthcare Ag | Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden |
EP1906993A2 (de) * | 2005-07-15 | 2008-04-09 | Novo Nordisk Health Care AG | Verwendung von faktor viia oder faktor viia-äquivalenten zur prävention oder abschwächung von hämorrhagiewachstum und/oder ödembildung nach interzerebraler blutung (ich) bei patienten unter einer anti-thrombozyten-therapie |
-
2005
- 2005-06-21 ES ES05756838T patent/ES2331653T3/es active Active
- 2005-06-21 CA CA002570330A patent/CA2570330A1/en not_active Abandoned
- 2005-06-21 JP JP2007517290A patent/JP5523671B2/ja not_active Expired - Fee Related
- 2005-06-21 BR BRPI0512316-0A patent/BRPI0512316A/pt not_active IP Right Cessation
- 2005-06-21 KR KR1020077001163A patent/KR20070027709A/ko not_active Application Discontinuation
- 2005-06-21 AU AU2005253749A patent/AU2005253749A1/en not_active Abandoned
- 2005-06-21 AT AT05756838T patent/ATE441430T1/de not_active IP Right Cessation
- 2005-06-21 RU RU2006144397/14A patent/RU2006144397A/ru not_active Application Discontinuation
- 2005-06-21 WO PCT/EP2005/052890 patent/WO2005123118A1/en active Application Filing
- 2005-06-21 DE DE602005016406T patent/DE602005016406D1/de active Active
- 2005-06-21 EP EP05756838A patent/EP1761274B1/de not_active Not-in-force
- 2005-06-21 MX MXPA06015045A patent/MXPA06015045A/es not_active Application Discontinuation
- 2005-06-29 US US11/169,933 patent/US20060019894A1/en not_active Abandoned
-
2007
- 2007-03-27 US US11/728,940 patent/US20070243183A1/en not_active Abandoned
-
2012
- 2012-05-10 JP JP2012108693A patent/JP2012197279A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20070243183A1 (en) | 2007-10-18 |
CA2570330A1 (en) | 2005-12-29 |
KR20070027709A (ko) | 2007-03-09 |
AU2005253749A1 (en) | 2005-12-29 |
EP1761274A1 (de) | 2007-03-14 |
BRPI0512316A (pt) | 2008-02-26 |
EP1761274B1 (de) | 2009-09-02 |
RU2006144397A (ru) | 2008-07-27 |
MXPA06015045A (es) | 2007-03-21 |
JP2008503543A (ja) | 2008-02-07 |
WO2005123118A1 (en) | 2005-12-29 |
JP5523671B2 (ja) | 2014-06-18 |
DE602005016406D1 (de) | 2009-10-15 |
US20060019894A1 (en) | 2006-01-26 |
JP2012197279A (ja) | 2012-10-18 |
ES2331653T3 (es) | 2010-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200716145A (en) | Use of LGG in the manufacture of a medicament for the prevention or treatment of respiratory allergies | |
ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
HK1124546A1 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
DE502005001828D1 (de) | Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms | |
ATE441430T1 (de) | Faktor viia oder faktor viia äquivaltenen zur prävention oder abschwächung des wachstums von hämorrhagien und/oder der ídemerzeugung nach intrazerebraler hämorrhagie (ich) | |
DE602005018763D1 (de) | Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität | |
MX2009004324A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematologicas. | |
MY150903A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
ATE464895T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen | |
WO2009079451A3 (en) | Compositions and methods of promoting wound healing | |
ATE497809T1 (de) | Myricitrin verbindungen zur behandlung von schlafstörungen | |
TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
HUP0402421A2 (hu) | Mátrix-metalloproteinázokat gátló készítmény neopláziás betegségek kezelésére | |
TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
ATE526967T1 (de) | Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum | |
MXPA05001885A (es) | El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica. | |
ATE309817T1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
ATE479423T1 (de) | Vorrichtung für die topische anwendung des medizinischen ozons zur behandlung von erkrankungen der mundhöhle | |
ATE431741T1 (de) | Marrubin und zusammensetzung zur verringerung von schnarchen, verpackung und verfahren | |
WO2006076014A3 (en) | Interferon-alpha constructs for use in the treatment of sars | |
DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
EA201070193A1 (ru) | Лечение детских опухолей | |
WO2007009895A3 (en) | USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY | |
DE502004010212D1 (de) | Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse | |
EA200601853A1 (ru) | Лечение нарушенной дыхательной функции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |